Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
about
p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating proteinHighly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocyclesCerulein pancreatitis: oxidative stress, inflammation, and apoptosisTyrosine kinase - Role and significance in Cancer.Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer.Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinaseDioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylationTyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin IIFormation of nascent secretory vesicles from the trans-Golgi network of endocrine cells is inhibited by tyrosine kinase and phosphatase inhibitorsERBB receptors and cancer: the complexity of targeted inhibitorsAdenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.Piracy of decay-accelerating factor (CD55) signal transduction by the diffusely adhering strain Escherichia coli C1845 promotes cytoskeletal F-actin rearrangements in cultured human intestinal INT407 cells.Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expressionInhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachEngagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathwayProbing the probes: fitness factors for small molecule tools.Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression.Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signalingPDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8.Inhibiting signal transduction: recent advances in the development of receptor tyrosine kinase and Ras inhibitors.Pyruvate dehydrogenase complex deficiency caused by ubiquitination and proteasome-mediated degradation of the E1 subunit.Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.Enhancement of recombinant adeno-associated virus type 2-mediated transgene expression in a lung epithelial cell line by inhibition of the epidermal growth factor receptorInvolvement of tyrosine phosphorylation in the positive inotropic effect produced by H(1)-receptors with histamine in guinea-pig left atrium.Cardiac Na+-Ca2+ exchanger current induced by tyrphostin tyrosine kinase inhibitors.Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin-1 and norepinephrine in canine ventricular myocardium.Insensitivity of cardiac delayed-rectifier I(Kr) to tyrosine phosphorylation inhibitors and stimulatorsFunctional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis.Activation of phospholipase C in human B cells is dependent on tyrosine phosphorylation.Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of alpha-thrombin in rabbit aortic rings.Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells.Crystal structure of 2-[2-(benz-yloxy)benzyl-idene]malono-nitrilePharmacology of second messengers: a critical appraisal.Tumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx.Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153Differential effect of polyunsaturated fatty acids on cell proliferation during human epithelial in vitro carcinogenesis: involvement of epidermal growth factor receptor tyrosine kinaseStaurosporine inhibits agrin-induced acetylcholine receptor phosphorylation and aggregation
P2860
Q24563005-E88196E0-367A-4989-8511-45E70D294086Q24614202-5FC20788-B46A-45C6-BF5E-135AF6967BCCQ24615203-1E512B45-C3F3-4668-8EC9-56224563F63DQ24791430-C32D0F54-55BB-4C81-8E70-493256422932Q24814879-869F8D1F-CB5A-41C9-86D1-C9588B8A71F0Q28215911-B6020C3B-38A3-4FC8-858B-9A684587B61DQ28343069-48FFA199-35B8-461D-8679-BBD0D2160ACBQ28355401-65B6B007-6C25-43DA-98FC-FFB9793259CCQ28567654-B2492540-546A-41AE-BA75-B4E798AB4677Q29619520-F7BF9670-2507-46B0-9BBA-580BFC1644ADQ30537881-B9DB1C52-B117-49E2-8091-817805FC5D59Q33760495-7C1A044A-7368-4524-AAD1-69BDC1C7FB0BQ33786039-B273E92A-B25A-4380-A752-739ABE34CDF0Q33925323-419BC8EB-4965-4FAF-ABFA-810893073279Q33957986-77386199-D8C2-439D-B32A-4B31CFFA4ABAQ34001269-9CFCCC6D-8E45-4CCE-8666-498B20FD5A17Q34007141-9810F724-02B6-416C-B662-30A6BE834FAEQ34036893-24F3813E-CA1B-406B-8BFD-2DE88AD9F75CQ34140712-56E2A615-93B2-4C3F-AC5D-5D60DFBF1211Q34519864-D21C9B9A-C4C3-46AF-8597-0481C5D9A97AQ34543940-A2378CDD-BADC-491F-AAAB-D0CD532F5694Q34651534-7A87EFF2-EDF9-48BD-BE6B-F2BF0CD49854Q34699604-82A18BE4-BE69-49E7-AACC-33E066EDB57FQ34717968-4FE392A8-1498-49CD-93D1-E98812D777CFQ34992505-0A794B56-6AE2-4581-87BB-CAAC9E65A0B8Q34997245-6D0C01A2-9341-47F6-8045-6330D1F791D0Q35042326-75FE3F46-8FC8-4D83-9BB4-EF50DF9FE4EDQ35048466-B70B08A1-907E-4779-9B17-27DCB30A371CQ35048619-93D54E30-B29F-4EAC-B092-799D818DA4F7Q35546183-EB4307FE-DC13-401C-9451-EE91C69AD84DQ35789048-9A721E75-755F-41E6-8198-A8E33F0E450AQ35820741-9E42F6DD-4DEB-4F3A-B431-C8C119C775D9Q35872489-1538737A-4A87-4BE9-A4EC-7EFC2B23600AQ35873596-085DEB86-C8B1-49CC-A15F-6EE022500FE9Q36063879-8663D20C-49DE-4AFC-8E3E-57185DB4A02EQ36071589-B3C55CC3-E445-478B-A284-C5FC6648737FQ36125732-B7AD1E4F-0871-4C26-9991-6E1F98F88C10Q36134430-2F6A0D68-868B-49BA-A25F-E718707FA8BAQ36135848-378B836E-FC94-4795-9F5B-18B818439826Q36233907-01695476-231F-4B00-9A07-E778CCB034F8
P2860
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@ast
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@en
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@nl
type
label
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@ast
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@en
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@nl
prefLabel
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@ast
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@en
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@nl
P2093
P356
P1476
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors
@en
P2093
P304
P356
10.1021/JM00130A020
P407
P577
1989-10-01T00:00:00Z